Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Financial Stocks Softer Late Afternoon

Sector Update: Financial Stocks Softer Late Afternoon

MT newswireMT newswire2026/09/23 19:57
03:57 PM EDT, 09/23/2026 (MT Newswires) -- Financial stocks declined in late Wednesday afternoon trading, with the NYSE Financial Index shedding 0.7% and the State Street Financial Select Sector SPDR ETF (XLF) decreasing 0.4%. The Philadelphia Housing Index fell 1.8% and the State Street Real Estate Select Sector SPDR ETF (XLRE) lost 1.3%. Bitcoin (BTC-USD) fell 2.1% to $84,537, and the yield for 10-year US Treasuries jumped 14.1 basis points to 5.11%. In economic news, Federal Reserve Governor Michael Barr called for further interest rate increases to combat sticky inflation. Barr said "further policy adjustments" will likely be needed to ensure inflation comes down to the 2% target in a timely fashion. Last week, the Fed delivered its first rate hike in just over three years. Markets are now pricing in a 71% probability that the Fed will lift interest rates again by 25 basis points in October, according to the CME FedWatch tool. That's up from 55% on Tuesday. The September flash reading of manufacturing conditions from S&P Global rose to a 52-month high of 57 from 53.9 in August, and compared with 53.7 in a Bloomberg survey. US mortgage applications fell 1.5% for the week ending Sept. 18, compared with a decline of 4.1% in the week prior, as the 30-year fixed-rate mortgage rate increased to 7.12% from 6.97% over the same period. In corporate news, BlackRock (BLK) is directing more money into large-cap stocks in the US and is shifting some of its AI exposure from industry pioneers toward later adopters, Bloomberg reported, citing an investment outlook. BlackRock shares were down 0.4%. Blue Owl Capital (OWL) could see its junior loan to Loparex wiped out as Monarch Alternative Capital and General Atlantic lead a roughly $1 billion restructuring that will see them own a majority of the business, Bloomberg reported. Blue Owl shares were falling 2.7%. A Morgan Stanley (MS) employee accidentally leaked an internal list of more than 100 investment-banking deals the firm is monitoring and pitching in Asia, Bloomberg reported. Morgan Stanley shares were shedding 1%. Brookfield (BN) is nearing a deal to buy financial crime and compliance specialist Actimize from NICE (NICE) for $2 billion, Sky News reported. Brookfield shares were down 1.7%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53